Adamas to present at upcoming healthcare conferences

Emeryville, calif.--(business wire)--adamas pharmaceuticals, inc. (nasdaq: adms), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that neil f. mcfarlane, chief executive officer, is scheduled to present at the following investor conferences: 10th annual svb leerink global healthcare conference on wednesday, february 24 at 1:40 p.m. et (10:40 a.m. pt) cowen 41st annual healthcare conference
ADMS Ratings Summary
ADMS Quant Ranking